Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder

NCT01382719 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

612

Enrollment

INDUSTRY

Sponsor class

Conditions

Female Sexual Arousal Disorder
Hypoactive Sexual Desire Disorder

Interventions

DRUG: bremelanotide

Sponsor

Palatin Technologies, Inc